Peptide-oligourea chimeric compounds and methods of their use
US10398750B2 · kind B2 · utility
1Cited by
9References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 21, 2014 |
| Grant date | Sep 3, 2019 |
| Priority date | — |
| Expiry date | Aug 21, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present description provides compositions and methods for producing therapeutic oligomeric compounds. In another aspect the description provides methods for administering the oligomeric compounds for the treatment and prevention of disease in a mammal. In particular, the invention relates to medicaments comprising various novel oligomeric compounds and pharmaceutically acceptable salts thereof. The compounds of the invention may optionally be administered with at least one of a pharmaceutically acceptable excipient, additional pharmacologically active agent or a combination thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.